SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
American Journal of Alzheimer's Disease and Other Dementias®
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Zeisel, J.
Right arrow Articles by Raia, P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zeisel, J.
Right arrow Articles by Raia, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Nonpharmacological treatment for Alzheimer's disease: A mind-brain approach

John Zeisel, PhD

Hearthstone Alzheimer Care, Lexington, Massachusetts.

Paul Raia, PhD

Family Support and Patient Care, Alcheimer's Association of Eastern Massachusetts, Cambridge, Massachusetts.

A new paradigm is needed thatfocuses on minimizing the symptoms of Alzheimer's disease and related dementias rather than focusing only on a search for a cure. To include Alzheimer 's in the same class of diseases as can cer, multiple sclerosis, diabetes, congestive heartfailure, and degenerative arthritis places Alzheimer's in the realm of the medically and psychosocially understandable and manageable. A criticalfirst step toward making this shift is to examine carefully the way in which we define the disease. An approach to care for people with Alzheimer's results in treatment when it systematically compensates forfunctional losses of dementia by linking caregiving actions and environments to specific brain dysfunctions; namely, the neuropathology of the disease. The ultimate measures of success of such a treatment approach are improved quality of life, delayed institutionalization, slowed rate of progression of the disease, people who achieve their potential, and reduced needfor medication.

American Journal of Alzheimer's Disease and Other Dementias®, Vol. 15, No. 6, 331-340 (2000)
DOI: 10.1177/153331750001500603
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 GerontologistHome page
C. R. Kovach, Y. Taneli, P. Dohearty, A. M. Schlidt, S. Cashin, and A. L. Silva-Smith
Effect of the BACE Intervention on Agitation of People With Dementia
Gerontologist, December 1, 2004; 44(6): 797 - 806.
[Abstract] [Full Text] [PDF]

Home page
 GerontologistHome page
J. Zeisel, N. M. Silverstein, J. Hyde, S. Levkoff, M. P. Lawton, and W. Holmes
Environmental Correlates to Behavioral Health Outcomes in Alzheimer's Special Care Units
Gerontologist, October 1, 2003; 43(5): 697 - 711.
[Abstract] [Full Text] [PDF]


Advertisement